It was of note that the presence of both polymorphisms of APOA5 and ZPR1 in homozygosity showed a stronger relationship with moderate/severe NAFLD than the presence of other well-known factors, such as obesity or high glucose or TG concentrations. Here, APOA5 is linked to metabolic dysfunction-associated steatotic liver disease.